CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Chemon Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Chemon Inc
240
Nampyeong-ro, Yangji-myeon, Cheoin-gu
Phone: +82 313299900p:+82 313299900 YONGIN, 17162  South Korea Fax: +82 313299902f:+82 313299902
This company was Merged or Acquired on 8/16/2022.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Chemon Inc is a Korea-based company principally engaged in the provision of non-clinical testing services. The Company is engaged in the research and development of pharmaceuticals, foods, chemicals, cosmetics and other new substances. In addition, the Company is engaged in the provision of toxicity evaluation service, clinical pathology evaluation service, ecological impact evaluation service, safety pharmacology evaluation service and other services. The Company is also engaged in the research and development of natural science and engineering. The Company was established in 2000.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202212/31/2021Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Si HwanSong 61 3/29/2017 2/23/2017
Internal Auditor Yun JeongCho 34
Internal Auditor Yeong GwonGu 50
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 288 (As of 9/30/2022)
Outstanding Shares: 63,861,340 (As of 9/30/2022)
Shareholders: 49,521
Stock Exchange: KDQ
Fax Number: +82 313299902


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, April 16, 2024